Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72808 record(s)

Req # A-2020-000827

Adverse Drug Reaction (ADR) for Propiverine (MICTORYL): E2B_03204835.

Organization: Health Canada

21 page(s)
February 2021

Req # A-2020-000883

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-103849-493.

Organization: Health Canada

4 page(s)
February 2021

Req # A-2020-000899

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-108877-249.

Organization: Health Canada

41 page(s)
February 2021

Req # A-2020-001048

Adverse Reaction Reports (AERs). Report numbers: E2B_02570280, E2B_02570438, E2B_02570510, E2B_02572890, E2B_02573036, E2B_02573068, E2B_02573077, E2B_02573029, E2B_02573078, E2B_02573826.

Organization: Health Canada

203 page(s)
February 2021

Req # A-2020-001079

Adverse Drug Reaction (ADR). Report number: E2B_03256245.

Organization: Health Canada

11 page(s)
February 2021

Req # A-2020-001093

Adverse Reaction Reports (AERs). Report numbers: 000918074, E2B_03180329, E2B_03066329.

Organization: Health Canada

35 page(s)
February 2021

Req # A-2020-001106

Adverse Reaction Reports (AERs) for FLUDARABINE PHOSPHATE. Report numbers: E2B_03157812, E2B_03154000, E2B_03185091.

Organization: Health Canada

37 page(s)
February 2021

Req # A-2020-001109

Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03079317, E2B_03076907, E2B_03075342, E2B_03066329, E2B_03161923.

Organization: Health Canada

70 page(s)
February 2021

Req # A-2020-001121

Adverse Reaction Reports (AERs) for CEFIXIME. Report numbers: E2B_03008916, 000914834.

Organization: Health Canada

16 page(s)
February 2021

Req # A-2020-001140

Adverse Drug Reaction (ADR) for RANITIDINE HYDROCHLORIDE. Report number: 000673364.

Organization: Health Canada

2 page(s)
February 2021
Date modified: